Atria Investments’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$617K Buy
3,655
+692
+23% +$115K 0.01% 1398
2026
Q1
$502K Buy
2,963
+486
+20% +$82.5K 0.01% 1445
2025
Q4
$380K Sell
2,477
-282
-10% -$43K ﹤0.01% 1606
2025
Q3
$414K Sell
2,759
-266
-9% -$41.9K ﹤0.01% 1528
2025
Q2
$482K Sell
3,025
-37
-1% -$6K 0.01% 1440
2025
Q1
$508K Buy
3,062
+732
+31% +$120K 0.01% 1347
2024
Q4
$380K Sell
2,330
-378
-14% -$65.6K ﹤0.01% 1458
2024
Q3
$477K Buy
2,708
+212
+8% +$36.1K 0.01% 1346
2024
Q2
$384K Buy
+2,496
New +$376K 0.01% 1444

Other funds holding BCPC

Atria Investments's BCPC Position: Q2 2026 in Review

Atria Investments increased its Balchem Corp (BCPC) stake by 23% in Q2 2026, buying an estimated $115K and bringing the position to 3,655 shares worth $617K. The position accounts for 0.01% of the portfolio, ranked #1398.

Atria Investments first reported a position in BCPC in Q2 2024 and has held it in 9 quarters since. 417 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • Atria Investments held 3,655 shares of Balchem Corp worth $617K as of Q2 2026.
  • Atria Investments bought 692 Balchem Corp shares in Q2 2026, an estimated $115K.
  • Balchem Corp made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1398 holding.
  • Atria Investments first reported a position in Balchem Corp in Q2 2024 and has held it in 9 quarters since.
  • 417 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.